ProCE Banner Activity

At-A-Glance: Nursing Considerations for Adjuvant Treatment Approaches for Patients With HER2+ Early Breast Cancer

PDF
Download this pocket guide for a summary of the optimal use of dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients with HER2+ EBC at high risk of disease recurrence.

Released: April 18, 2018

Expiration: April 17, 2019

No longer available for credit.

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Genentech TEXT Only

Puma Biotechnology, Inc.